Male Urogenital Diseases

160 trials 69 recruiting

Filter these 160 trials by phase, country and sponsor.

Open in Search →

Interest of early erectile rehabilitation with Sildenafil after proctectomy for rectal cancer : Randomized controlled trial (RECTIL) Recruiting

2024-515431-30-00 Men treated with proctectomy for rectal cancer 5 2025-08-14
Darolutamide and bipolar androgen therapy for mCRPC patients (DaroBAT) Recruiting

2025-521051-23-00 metastatic castration-resistant prostate cancer 4 2025-08-06
SAKK 08/23: Addition of Darolutamide to first line treatment of mCRPC: a randomized open label phase II trial Recruiting

2024-512132-29-00 Metastatic castration-resistant prostate cancer 4 2025-08-06
EORTC-2238-GUCG: Improving impact of anti-androgen treatments on patient's daily life and their cancer Recruiting

2023-506817-23-01 Metastatic hormone naïve prostate cancer (mHNPC) 5 2025-05-23
Sclerotherapy of hydro and spermatoceles with 2ml Aetoxysclerol 30mg/ml vs. a combination of 2ml Aetoxysclerol 30mg/ml and 25ml of ethanol 9… Recruiting

2022-502284-38-00 Spermatocele 5 2025-05-05
Phase I/II study to evaluate the efficacy and safety of bacterial collagenase administered in patients with Peyronie's Disease Recruiting

2023-509621-45-00 Peyronie’s Disease 9 2025-04-22
Effect of low-dose arginine-vasopressin supplementation on post-transplant Acute Kidney Injury after liver transplantation - AVENIR Trial Recruiting

2023-506512-40-00 Acute Kidney Injury 5 2025-04-16
ReaLuP : Study on Re-treatment with Radiopharmaceutical Drug [177Lu]Lu-PSMA in Patients With Metastatic Castration-Resistant Prostate Cancer Recruiting

2024-512043-22-00 Metastatic prostate cancer 4 2025-04-11
Klinefelter syndrome – the effect of Testosterone treatment In PubertY A randomized, double-blind placebo-controlled intervention study ‘Th… Recruiting

2023-505854-16-00 47,XXY (Klinefelter syndrome) 6 2025-04-01
A no-profit, open-label, phase II pilot study on the efficacy and safety of Alpelisib in patients with Dent 2 disease (ALPEDENT study) Recruiting

2024-514196-17-00 Dent 2 disease 4 2025-03-14
Chronic anticoagulation in end-stage renal disease patients: pharmacocinetics and pharmacodynamic of a reduced dose regimen of rivaroxaban (… Recruiting

2023-505733-28-00 Chronic hemodialysis 4 2025-01-08
REINFORCE – Reducing infection-related readmissions following cystectomy. Recruiting

2024-514312-27-00 Bacterial infection 6 2025-01-07
Inventarisation of the value of FAPI and FDG-PET-CT in the diagnosis of acute phase Peyronie’s Disease Recruiting

2024-518838-82-00 Peyronie's Disease 6 2024-12-13
Clinical Efficacy of oral Fosfomycin Trometamol and Cefixime in the Treatment of Acute Bacterial Prostatitis (CEFOSPROST): a comparative, ra… Recruiting

2024-513465-39-00 Acute bacterial prostatitis 6 2024-12-04
Novel treatment with botulinum toxin for erectile dysfunction unresponsive to conventional treatment Recruiting

2024-514518-10-00 Erectile dysfunction 4 2024-10-31
CHASIT Recruiting

2024-516940-24-00 locally advanced urothelial cancer. 4 2024-10-29
DAROTAXEL Recruiting

2024-516939-28-00 metastatic castration-resistant prostate cancer 4 2024-10-28
Evaluation of PSMA-PET and mpMRI in high-risk prostate cancer – using histopathologic validation Recruiting

2022-501892-14-00 Prostate cancer 5 2024-10-14
A Phase I/II Study of Neoadjuvant, Intra-arterial Administration of [177Lu]Lu-PSMA-617 in Subjects with High-risk, Localised or Locally Adva… Recruiting

2022-500838-28-00 high-risk localized or locally advanced prostate cancer 9 2024-09-10
Study evaluating whether giving 177Lu-PSMA-617 to men having a spreading prostate cancer which does not respond well to the current standard… Recruiting

2022-502408-57-00 Novo metastatic hormone-sensitive prostate cancer (mHSP 5 2024-09-04
Transdermal estradiol and exercise in mitigating adverse effects of androgen deprivation therapy for prostate cancer radiation therapy (ESTR… Recruiting

2023-504704-28-00 Prostate cancer 4 2024-09-01
Effectiveness and safety of combined autologous Platelet Rich Plasma and Focal Shockwave Therapy for the treatment of erectile dysfunction Recruiting

2024-517248-73-00 Erectile dysfunction 11 2024-08-19
A Phase 2 clinical study to assess efficacy of induction carboplatin/paclitaxel + pembrolizumab for locoregionally advanced penile cancer: P… Recruiting

2023-506731-15-00 locoregionally advanced penile cancer 4 2024-08-13
Talazoparib plus Enzalutamide after progression to prior ARPi in Metastatic Prostate Cancer Recruiting

2023-510536-37-00 Prostate Cancer 4 2024-07-05